financetom
Business
financetom
/
Business
/
CBS News President McMahon to step down, memo shows
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
CBS News President McMahon to step down, memo shows
May 26, 2025 10:20 AM

May 19 (Reuters) - Wendy McMahon, the president and CEO

of CBS News, will step down from her position, as the company

and her have differing views on the path forward, according to a

memo seen by Reuters on Monday.

McMahon, president and CEO of Paramount Global ( PARAA )-owned

CBS News and Stations and CBS Media Ventures since

2023, said in the memo that the last few months have been

challenging.

"It's become clear that the company and I do not agree on

the path forward. It's time for me to move on and for this

organization to move forward with new leadership," McMahon said.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Sasol Names Walt Bruns as Chief Financial Officer
Sasol Names Walt Bruns as Chief Financial Officer
Aug 13, 2024
04:00 AM EDT, 08/13/2024 (MT Newswires) -- Sasol ( SSL ) said Tuesday that Walt Bruns will replace Hanre Rossouw as chief financial officer, effective Sept. 1. As announced on May 2, Rossouw is stepping down from the role to pursue a career opportunity, the company said. Bruns currently serves as the CFO of Sasol Southern Africa. He has been...
Kyverna Therapeutics Says FDA Grants Regenerative Medicine Advanced Therapy Designation to Autoimmune Disorder Drug
Kyverna Therapeutics Says FDA Grants Regenerative Medicine Advanced Therapy Designation to Autoimmune Disorder Drug
Aug 13, 2024
03:35 AM EDT, 08/13/2024 (MT Newswires) -- Kyverna Therapeutics ( KYTX ) said late Monday the US Food and Drug Administration has granted regenerative medicine advanced therapy designation to its KYV-101 experimental therapy, which is being developed to treat progressive myasthenia gravis. Myasthenia gravis is an autoimmune disorder associated with muscle weakness. The designation allows Kyverna to leverage on more...
Kodiak Gas Services Q2 Earnings Fall, Revenue Rises
Kodiak Gas Services Q2 Earnings Fall, Revenue Rises
Aug 13, 2024
03:54 AM EDT, 08/13/2024 (MT Newswires) -- Kodiak Gas Services ( KGS ) reported Q2 earnings Monday of $0.06 per diluted share, down from $0.30 a year earlier. Two analysts surveyed by Capital IQ expected $0.49. Revenue for the quarter ended June 30 was $309.7 million, compared with $203.3 million a year earlier. Analysts polled by Capital IQ expected $311.4...
Citius Pharmaceuticals Completes Merger of Oncology Subsidiary With Blank Check Firm TenX Keane
Citius Pharmaceuticals Completes Merger of Oncology Subsidiary With Blank Check Firm TenX Keane
Aug 13, 2024
03:41 AM EDT, 08/13/2024 (MT Newswires) -- Citius Pharmaceuticals ( CTXR ) said late Monday it has completed the pending merger of its oncology subsidiary and blank check firm TenX Keane Acquisition (TENK). The combined company has been renamed Citius Oncology ( TENK ), with its stock expected to debut on Nasdaq on Aug. 13 under the ticker, CTOR. Pursuant...
Copyright 2023-2026 - www.financetom.com All Rights Reserved